Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 192.87 USD -0.3% Market Closed
Market Cap: 340.8B USD
Have any thoughts about
Abbvie Inc?
Write Note

EV/OCF
Enterprise Value to OCF

23.7
Current
12.8
Median
5.8
Industry
Higher than median
Higher than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
23.7
=
Enterprise Value
392B USD
/
Operating Cash Flow
16.5B USD
All Countries
Close
Market Cap EV/OCF
US
Abbvie Inc
NYSE:ABBV
340.8B USD 23.7
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 345.3
US
Amgen Inc
NASDAQ:AMGN
156.4B USD 27.7
US
Gilead Sciences Inc
NASDAQ:GILD
129.7B USD 11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.9B USD -224.1
US
Epizyme Inc
F:EPE
94.1B EUR -472.4
AU
CSL Ltd
ASX:CSL
124.1B AUD 32
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.8B USD 11.8
US
Seagen Inc
F:SGT
39.3B EUR -73.9
NL
argenx SE
XBRU:ARGX
36.3B EUR -134.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
33.2B USD -3 788.2
 
US
Abbvie Inc
NYSE:ABBV
Average EV/OCF: 21.4
23.7
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -238 345.3
US
Amgen Inc
NASDAQ:AMGN
27.7
US
Gilead Sciences Inc
NASDAQ:GILD
11.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -224.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472.4
AU
CSL Ltd
ASX:CSL
32
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -73.9
NL
argenx SE
XBRU:ARGX
Negative Multiple: -134.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -3 788.2

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A